At a glance
ClinicalIndex Comparison RecordN/ACompleted· 44 enrolled
Drug / intervention
modified vaginal tampondevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Source and Prevention of Urinary Contamination of Vaginal Tampons During 18F-2-fluoro-2-deoxy-D-glucose (FDG) Positron Emission Tomography (PET) Examinations
In Brief
A clinical study evaluating modified vaginal tampon for Cancer. Completed, enrolled 44 participants across 1 site.
Detailed Summary
The etiology of FDG uptake in vaginal tampons during PET/CT examinations remains unclear and can potentially impair image interpretation. The aim of this study is to determine the etiology of this artefact and identify potential means how to prevent it.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCancer
CountriesSwitzerland
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2010
Primary CompletionAug 2010
Study CompletionSep 2010
First PostedOct 2010
TodayJul 2026
First PostedOct 6, 2010
Enrollment StartFeb 2, 2010
Primary CompletionAug 2, 2010
Study CompletionSep 30, 2010
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 15.7 years ago
Interventions
modified vaginal tampondevice
modified vaginal tampons versus unmodified vaginal tampons, comparing the urinary contamination